Biospectal

1. Executive Summary (Confidence: High)

Biospectal is transforming the global management of hypertension by democratizing access to clinical-grade blood pressure (BP) monitoring. Headquartered in Lausanne, the company’s flagship product, OptiBP™, is the first software-as-a-medical-device (SaMD) to receive European CE-MDR Class IIa certification for BP measurement using only a smartphone camera. By utilizing photoplethysmography (PPG) and advanced AI algorithms to analyze blood flow in the fingertip, Biospectal has eliminated the need for cumbersome and uncomfortable cuffs. With backing from world-class organizations like the Bill & Melinda Gates Foundation and Labcorp, Biospectal is scaling its multi-channel commercial activity to address the needs of 1.3 billion people suffering from hypertension worldwide.